The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

A rare cell in the lining of lungs is fundamental to the organ-wide response necessary to repair damage from toxins like ...

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction ...

A biopsy is the best way to tell for certain if an abnormal area is a pre-cancer, an invasive cancer, or neither. Types of cervical biopsies. Several types of biopsies can be used to diagnose cervical ...

The global cancer biopsy market is estimated to be valued at USD 35.8 billion in 2025 and is projected to reach USD 195.5 ...

Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique challenges in pain-insensitive individuals.

Introduction The promise of benefits from lung cancer screening is tempered by the false positive rate and the need to perform diagnostic procedures to determine the aetiology of the solitary ...

Navigational bronchoscopy was noninferior to CT-guided biopsy when assessing diagnostic accuracy in patients with lung ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Thoracoscopic procedures reduce morbidity and the length of hospitalization compared to lung biopsy through open thoracotomy, while providing comparably diagnostic specimens.